36 related articles for article (PubMed ID: 11179477)
1. Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy.
Harima Y; Sawada S; Nagata K; Sougawa M; Ostapenko V; Ohnishi T
Int J Oncol; 2001 Mar; 18(3):493-7. PubMed ID: 11179477
[TBL] [Abstract][Full Text] [Related]
2. Expression of PTEN and survivin in cervical cancer: promising biological markers for early diagnosis and prognostic evaluation.
Lu D; Qian J; Yin X; Xiao Q; Wang C; Zeng Y
Br J Biomed Sci; 2012; 69(4):143-6. PubMed ID: 23310986
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
[TBL] [Abstract][Full Text] [Related]
4. Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian population.
Thakur N; Hussain S; Nasare V; Das BC; Basir SF; Bharadwaj M
Mol Biol Rep; 2012 Jan; 39(1):407-14. PubMed ID: 21567202
[TBL] [Abstract][Full Text] [Related]
5. AACR Project GENIE: Powering Precision Medicine through an International Consortium.
AACR Project GENIE Consortium
Cancer Discov; 2017 Aug; 7(8):818-831. PubMed ID: 28572459
[TBL] [Abstract][Full Text] [Related]
6. PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma.
Cao L; Ma X; Zhang J; Yang C; Rong P; Wang W
Discov Oncol; 2023 Jul; 14(1):134. PubMed ID: 37470852
[TBL] [Abstract][Full Text] [Related]
7. Eight Aging-Related Genes Prognostic Signature for Cervical Cancer.
Yin M; Weng Y
Int J Genomics; 2023; 2023():4971345. PubMed ID: 36880057
[TBL] [Abstract][Full Text] [Related]
8. PRDM4 inhibits cell proliferation and tumorigenesis by inactivating the PI3K/AKT signaling pathway through targeting of PTEN in cervical carcinoma.
Yang WT; Chen M; Xu R; Zheng PS
Oncogene; 2021 May; 40(18):3318-3330. PubMed ID: 33846573
[TBL] [Abstract][Full Text] [Related]
9. New novel non-MHC genes were identified for cervical cancer with an integrative analysis approach of transcriptome-wide association study.
Chen H; Wang T; Huang S; Zeng P
J Cancer; 2021; 12(3):840-848. PubMed ID: 33403041
[TBL] [Abstract][Full Text] [Related]
10. Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis.
Wei J; Wang Y; Shi K; Wang Y
Biomed Res Int; 2020; 2020():8959210. PubMed ID: 32258155
[TBL] [Abstract][Full Text] [Related]
11. PTEN and Gynecological Cancers.
Nero C; Ciccarone F; Pietragalla A; Scambia G
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569439
[TBL] [Abstract][Full Text] [Related]
12. Notoginsenoside R7 suppresses cervical cancer via PI3K/PTEN/Akt/mTOR signaling.
Li L; Sun JX; Wang XQ; Liu XK; Chen XX; Zhang B; He ZD; Liu DZ; Chen LX; Wang LW; Huang Z
Oncotarget; 2017 Dec; 8(65):109487-109496. PubMed ID: 29312623
[TBL] [Abstract][Full Text] [Related]
13. Loss and reduced expression of PTEN correlate with advanced-stage gastric carcinoma.
Zhu X; Qin X; Fei M; Hou W; Greshock J; Bachman KE; Kang J; Qin CY
Exp Ther Med; 2013 Jan; 5(1):57-64. PubMed ID: 23251242
[TBL] [Abstract][Full Text] [Related]
14. PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.
Snietura M; Jaworska M; Mlynarczyk-Liszka J; Goraj-Zajac A; Piglowski W; Lange D; Wozniak G; Nowara E; Suwinski R
PLoS One; 2012; 7(3):e33396. PubMed ID: 22413021
[TBL] [Abstract][Full Text] [Related]
15. Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.
He L; Ingram A; Rybak AP; Tang D
J Clin Invest; 2010 Jun; 120(6):2094-108. PubMed ID: 20458142
[TBL] [Abstract][Full Text] [Related]
16. UVB-induced ERK/AKT-dependent PTEN suppression promotes survival of epidermal keratinocytes.
Ming M; Han W; Maddox J; Soltani K; Shea CR; Freeman DM; He YY
Oncogene; 2010 Jan; 29(4):492-502. PubMed ID: 19881543
[TBL] [Abstract][Full Text] [Related]
17. The drug-resistance to gefitinib in PTEN low expression cancer cells is reversed by irradiation in vitro.
Zhuang HQ; Wang J; Yuan ZY; Zhao LJ; Wang P; Wang CL
J Exp Clin Cancer Res; 2009 Sep; 28(1):123. PubMed ID: 19723324
[TBL] [Abstract][Full Text] [Related]
18. PI3K/PTEN signaling in angiogenesis and tumorigenesis.
Jiang BH; Liu LZ
Adv Cancer Res; 2009; 102():19-65. PubMed ID: 19595306
[TBL] [Abstract][Full Text] [Related]
19. PTEN: new insights into its regulation and function in skin cancer.
Ming M; He YY
J Invest Dermatol; 2009 Sep; 129(9):2109-12. PubMed ID: 19340009
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.
Wiencke JK; Zheng S; Jelluma N; Tihan T; Vandenberg S; Tamgüney T; Baumber R; Parsons R; Lamborn KR; Berger MS; Wrensch MR; Haas-Kogan DA; Stokoe D
Neuro Oncol; 2007 Jul; 9(3):271-9. PubMed ID: 17504928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
